US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
US8673924B2
(en)
|
2002-09-04 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
US20070179161A1
(en)
*
|
2003-03-31 |
2007-08-02 |
Vernalis (Cambridge) Limited. |
Pyrazolopyrimidine compounds and their use in medicine
|
EP1782859A3
(fr)
*
|
2003-04-11 |
2009-09-30 |
High Point Pharmaceuticals, LLC |
Utilisation thérapeutique de pyrazolo [1,5- a] pyrimidines
|
RU2375350C2
(ru)
|
2003-06-04 |
2009-12-10 |
Смитклайн Бичам Корпорейшн |
Азотсодержащие производные гетероарила
|
KR20060054410A
(ko)
|
2003-08-01 |
2006-05-22 |
제네랩스 테크놀로지스, 인코포레이티드 |
플라비비리다에에 대한 2고리 이미다졸 유도체
|
JP4682155B2
(ja)
|
2004-01-21 |
2011-05-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
C型肝炎ウイルスに対して活性な大環状ペプチド
|
DK1718608T3
(da)
|
2004-02-20 |
2013-10-14 |
Boehringer Ingelheim Int |
Virale polymeraseinhibitorer
|
WO2006040646A1
(fr)
*
|
2004-10-14 |
2006-04-20 |
Pfizer, Inc. |
Amides de benzimidazole ou d'indole en tant qu'inhibiteurs de pin1
|
GB0519957D0
(en)
|
2005-09-30 |
2005-11-09 |
Sb Pharmco Inc |
Chemical compound
|
CA2585383A1
(fr)
*
|
2004-10-29 |
2006-05-11 |
Gerald W. Shipps, Jr. |
5-oxo pyrazoles substitues et [1,2,4]triazoles utiles comme agents antiviraux
|
WO2006088246A1
(fr)
*
|
2005-02-18 |
2006-08-24 |
Takeda Pharmaceutical Company Limited |
Agent de controle de la fonction du recepteur gpr34
|
KR20080087070A
(ko)
*
|
2005-05-20 |
2008-09-30 |
알란토스 파마슈티컬즈 홀딩, 인코포레이티드 |
피리미딘 또는 트리아진 융합된 비시클릭 메탈로프로테아제억제제
|
US20070155738A1
(en)
*
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
KR100700676B1
(ko)
*
|
2005-06-24 |
2007-03-28 |
(주) 비엔씨바이오팜 |
6―(4―치환된―아닐리노)피리미딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
|
US8076365B2
(en)
|
2005-08-12 |
2011-12-13 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
SI1940786T1
(sl)
*
|
2005-09-16 |
2010-11-30 |
Arrow Therapeutics Ltd |
Bifenilni derivati in njihova uporaba pri zdravljenju hepatitisa C
|
CA2627623C
(fr)
*
|
2005-10-06 |
2014-04-22 |
Schering Corporation |
Methodes destinees a inhiber des proteines kinases
|
KR20080063806A
(ko)
|
2005-10-06 |
2008-07-07 |
쉐링 코포레이션 |
단백질 키나제 억제제로서의 피라졸로피리미딘
|
JP4847275B2
(ja)
*
|
2005-10-21 |
2011-12-28 |
田辺三菱製薬株式会社 |
ピラゾロ[1,5−a]ピリミジン化合物
|
CN101296699B
(zh)
*
|
2005-10-21 |
2013-01-02 |
田边三菱制药株式会社 |
吡唑并[1,5-a]嘧啶化合物
|
AR056876A1
(es)
|
2005-10-21 |
2007-10-31 |
Tanabe Seiyaku Co |
Compuestos de pirazolo[1-5-a]pirimidina, antagonistas de receptores canabinoides cb1, composiciones farmaceuticas que los contienen y usos en el tratamiento de enfermedades del sistema nervioso central, tales como trastornos psicoticos, neurologicos y similares
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
JP2009533463A
(ja)
*
|
2006-04-11 |
2009-09-17 |
ノバルティス アクチエンゲゼルシャフト |
βアミノ酸を含むHCV阻害剤およびその使用
|
WO2007118844A1
(fr)
*
|
2006-04-13 |
2007-10-25 |
Basf Se |
Pyrazolopyrimidines substituées, leur procédé de préparation, leur utilisation pour lutter contre les champignons nuisibles, et agents les contenant
|
TWI419889B
(zh)
*
|
2006-07-05 |
2013-12-21 |
Mitsubishi Tanabe Pharma Corp |
吡唑并〔1,5-a〕嘧啶化合物
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
WO2008003753A1
(fr)
*
|
2006-07-07 |
2008-01-10 |
Biovitrum Ab (Publ) |
Analogues de pyrazolo [1,5-a] pyrimidine utilisables comme inhibiteurs de l'activité stéaroyl-coa désaturase (scd)
|
PL2054416T3
(pl)
|
2006-08-04 |
2011-05-31 |
Merz Pharma Gmbh & Co Kgaa |
Podstawione pirazolopirymidyny, sposób ich wytwarzania oraz ich zastosowanie w medycynie
|
JP2010500978A
(ja)
|
2006-08-17 |
2010-01-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ウイルスポリメラーゼインヒビター
|
WO2008036967A2
(fr)
*
|
2006-09-22 |
2008-03-27 |
Reddy Us Therapeutics, Inc. |
Nouveaux composes heterocycliques utilises en tant qu'activateurs de la synthase d'acide lipoique
|
JP5442448B2
(ja)
|
2006-12-22 |
2014-03-12 |
アステックス、セラピューティックス、リミテッド |
Fgfrインヒビターとしての二環式ヘテロ環式化合物
|
AU2007337895C1
(en)
|
2006-12-22 |
2014-07-31 |
Astex Therapeutics Limited |
Tricyclic amine derivatives as protein tyrosine kinase inhibitors
|
US20080255153A1
(en)
*
|
2007-03-28 |
2008-10-16 |
Biovitrum Ab (Publ) |
New compounds
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
JP4837701B2
(ja)
*
|
2007-04-20 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
ATE548044T1
(de)
|
2007-05-04 |
2012-03-15 |
Vertex Pharma |
Kombinationstherapie zur behandlung von hiv- infektionen
|
US8242140B2
(en)
|
2007-08-03 |
2012-08-14 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8729264B2
(en)
*
|
2007-09-28 |
2014-05-20 |
Kyowa Hakko Kirin Co., Ltd. |
Agent for prevention and/or treatment of skin diseases
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
JP5529036B2
(ja)
|
2007-12-05 |
2014-06-25 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
フッ素化トリペプチドhcvセリンプロテアーゼ阻害剤
|
AU2008338273B2
(en)
|
2007-12-19 |
2014-10-02 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
EP2085398A1
(fr)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, leur procédé de préparation et leur utilisation en tant que médicament
|
US7806058B2
(en)
*
|
2008-03-28 |
2010-10-05 |
Gunderson Llc |
Tank car stub sill attachment
|
DE102008022221A1
(de)
*
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
US8809344B2
(en)
|
2008-10-29 |
2014-08-19 |
Apath, Llc |
Compounds, compositions, and methods for control of hepatitis C viral infections
|
TW201031675A
(en)
|
2008-12-23 |
2010-09-01 |
Pharmasset Inc |
Synthesis of purine nucleosides
|
EP2376088B1
(fr)
|
2008-12-23 |
2017-02-22 |
Gilead Pharmasset LLC |
Phosphoramidates de nucléosides de type 2-amino-purine 6-O-substituée
|
EP2376514A2
(fr)
|
2008-12-23 |
2011-10-19 |
Pharmasset, Inc. |
Analogues de nucléoside
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
JP5639155B2
(ja)
|
2009-05-13 |
2014-12-10 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
C型肝炎ウイルスインヒビターとしての大環状化合物
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
US20110034469A1
(en)
|
2009-08-04 |
2011-02-10 |
Takeda Pharmaceutical Company Limited |
Heterocyclic Compound
|
HUE028259T2
(en)
|
2009-08-10 |
2016-12-28 |
Samumed Llc |
Inhibitors of Wnt signaling signal indazole and their therapeutic use
|
JP5822844B2
(ja)
*
|
2009-12-21 |
2015-11-24 |
サミュメッド リミテッド ライアビリティ カンパニー |
1H−ピラゾロ[3,4−b]ピリジンおよびその治療的使用
|
AU2011221075B2
(en)
|
2010-02-26 |
2013-12-19 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolopyrimidine compounds and their use as PDE10 inhibitors
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
UY33311A
(es)
|
2010-03-31 |
2011-10-31 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
UY33312A
(es)
|
2010-03-31 |
2011-10-31 |
Pharmasset Inc |
Fosforamidato de nucleosido de purina
|
RS54761B1
(sr)
|
2010-06-24 |
2016-10-31 |
Gilead Sciences |
Pirazolo[1,5-a]pirimidini i-triazini kao antiviralni agensi
|
RS54638B1
(en)
|
2010-09-21 |
2016-08-31 |
Enanta Pharmaceuticals, Inc. |
HCV SERIN PROTEASE INHIBITORS DERIVED FROM MACROCYCLIC PROLINE
|
US8841275B2
(en)
|
2010-11-30 |
2014-09-23 |
Gilead Pharmasset Llc |
2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
|
WO2012139876A1
(fr)
|
2011-04-14 |
2012-10-18 |
Merz Pharma Gmbh & Co. Kgaa |
Formulations entériques de modulateurs de récepteur de glutamate métabotropique
|
EP2723746A1
(fr)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Composés inhibiteurs de la kinase atr
|
IN2014CN02646A
(fr)
|
2011-09-14 |
2015-08-07 |
Samumed Llc |
|
CN102503945A
(zh)
*
|
2011-11-28 |
2012-06-20 |
华东理工大学 |
能够抑制表皮生长因子受体的化合物及其应用
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
AU2012351748B2
(en)
|
2011-12-12 |
2016-04-14 |
Dr. Reddy's Laboratories Ltd. |
Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors
|
WO2013087808A1
(fr)
|
2011-12-15 |
2013-06-20 |
Merz Pharma Gmbh & Co. Kgaa |
Composition pharmaceutique comprenant une pyrazolopyrimidine et une cyclodextrine
|
WO2013087815A1
(fr)
|
2011-12-15 |
2013-06-20 |
Merz Pharma Gmbh & Co. Kgaa |
Composition pharmaceutique liquide contenant un dérivé de pyrazolopyrimidine et utilisations pharmaceutiques de celle-ci
|
WO2013096681A1
(fr)
*
|
2011-12-22 |
2013-06-27 |
Gilead Sciences, Inc. |
Pyrazolo[1,5]pyrimidines en tant qu'agents antiviraux
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
LT2838900T
(lt)
|
2012-04-17 |
2019-11-11 |
Gilead Sciences Inc |
Junginiai ir būdai, skirti priešvirusinei terapijai
|
NZ724837A
(en)
*
|
2012-05-04 |
2018-05-25 |
Samumed Llc |
1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
CN104507481B
(zh)
*
|
2012-05-23 |
2017-08-04 |
萨维拉制药有限公司 |
用于治疗、改善或预防病毒疾病的7‑氧代‑4,7‑二氢‑吡唑并[1,5‑a]嘧啶衍生物
|
PT2941432T
(pt)
|
2012-12-07 |
2018-06-01 |
Vertex Pharma |
2-amino-6-fluoro-n-(5-fluoro-4-(4-(4-(oxetan-3- il)piperazina-1-carbonil)piperidin-1-il)piridin-3- il)pirazolo[1,5alfa]pirimidina-3-carboxamida como inibidor da quinase atr
|
MX370487B
(es)
|
2013-01-08 |
2019-12-16 |
Samumed Llc |
Inhibidores de 3-(benzo-imidazol-2-il)-indazol de la senda de señalización de wnt y usos terapéuticos de los mismos.
|
CN105980386B
(zh)
|
2013-03-13 |
2021-08-13 |
基因泰克公司 |
吡唑并化合物及其用途
|
JP2016512239A
(ja)
|
2013-03-15 |
2016-04-25 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Atrキナーゼの阻害剤として有用な化合物
|
EP2970288A1
(fr)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Incorporated |
Composés utiles en tant qu'inhibiteurs de la kinase atr
|
US9663519B2
(en)
|
2013-03-15 |
2017-05-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
MX2016002185A
(es)
|
2013-08-27 |
2016-06-06 |
Gilead Pharmasset Llc |
Formulacion combinada de dos compuestos antivirales.
|
US9505767B2
(en)
|
2013-09-05 |
2016-11-29 |
Genentech, Inc. |
Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors
|
PT3077397T
(pt)
|
2013-12-06 |
2020-01-22 |
Vertex Pharma |
Composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor da atr quinase, a sua preparação, diferentes formas sólidas e derivados radiomarcados do mesmo
|
LT3149001T
(lt)
|
2014-05-28 |
2019-08-12 |
Novartis Ag |
Naujieji pirazolo pirimidino dariniai ir jų panaudojimas kaip malt1 inhibitorių
|
CN107074863B
(zh)
|
2014-06-05 |
2019-12-03 |
沃泰克斯药物股份有限公司 |
Atr激酶抑制剂的制备方法及其不同的固体形式
|
MX2016016115A
(es)
|
2014-06-17 |
2017-03-08 |
Vertex Pharma |
Metodo para tratar cancer usando una combinacion de inhibidores de chk1 y relacionado con atm y rad3 (atr).
|
WO2016040190A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040180A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040185A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine et ses utilisations thérapeutiques
|
WO2016040188A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040181A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040193A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040182A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine et ses utilisations thérapeutiques
|
WO2016040184A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023984A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines et leurs utilisations thérapeutiques
|
WO2017023993A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017024003A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017024021A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
WO2017024004A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023996A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines et leurs utilisations thérapeutiques
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023987A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines et leurs utilisations thérapeutiques
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017024015A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
WO2017079759A1
(fr)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(3h-indazol-3-yl)-1h-imidazo[4,5-c]pyridines et leurs utilisations anti-inflammatoires
|
HRP20221446T1
(hr)
|
2016-06-01 |
2023-01-06 |
Biosplice Therapeutics, Inc. |
Postupci za pripremu n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida
|
EP3507290A1
(fr)
|
2016-08-31 |
2019-07-10 |
Agios Pharmaceuticals, Inc. |
Inhibiteurs de processus métaboliques cellulaires
|
BR112019008061A2
(pt)
|
2016-10-21 |
2019-09-17 |
Samumed Llc |
métodos de uso de indazol-3-carboxamidas e seu uso como inibidores da via de sinalização de wnt/b-catenina
|
JP2019533702A
(ja)
|
2016-11-07 |
2019-11-21 |
サミュメッド リミテッド ライアビリティ カンパニー |
単回用量の調整済み注射用製剤
|
EP3412658A1
(fr)
*
|
2017-06-09 |
2018-12-12 |
Solvay Sa |
Procédés pour la préparation de dérivés de pyrazole substitués par un soufre
|
MX2020002869A
(es)
|
2017-09-15 |
2020-07-24 |
Aduro Biotech Inc |
Compuestos de pirazolopirimidinona y usos de los mismos.
|
EP3873911A4
(fr)
|
2018-10-30 |
2022-06-22 |
Kronos Bio, Inc. |
Composés, compositions et procédés de modulation de l'activité de cdk9
|
CN110563732B
(zh)
*
|
2019-09-04 |
2021-11-26 |
南方医科大学 |
一种7-(三甲氧基苯基)-吡咯并[2,3-d]嘧啶及其应用
|
WO2021142420A1
(fr)
*
|
2020-01-10 |
2021-07-15 |
Kapoor Tarun M |
Inhibiteurs pyrazolo [1,5-a] pyrimidine-7 (4h)-one de dynéine
|
EP4229063A1
(fr)
*
|
2020-10-19 |
2023-08-23 |
TME Therapeutics LLC |
Nouveaux inhibiteurs de la pikfyve et leurs méthodes d'utilisation
|
TW202233620A
(zh)
|
2020-10-23 |
2022-09-01 |
南韓商日東製藥股份有限公司 |
Cftr調節劑化合物、組合物及其用途
|
WO2023141866A1
(fr)
|
2022-01-27 |
2023-08-03 |
Janssen Pharmaceutica Nv |
Pyrazolopyrimidines utilisées en tant que modulateurs de la spermine oxydase
|